av/beximco-pharmaceuticals-ltd--big.svg

COM:BEXIMCOPHARMA

Beximco Pharma

  • Stock

GBP

Last Close

33.50

22/11 14:00

Market Cap

1.73M

Beta: -

Volume Today

516.64K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Jun '17
Jun '18
Jun '19
Jun '20
Jun '21
Jun '22
Jun '23
Jun '24
average inventory
2.84B
-
2.95B
3.84%
3.21B
8.98%
3.74B
16.45%
4.91B
31.41%
6.19B
25.91%
6.69B
8.06%
7.26B
8.63%
9.46B
30.32%
12.04B
27.20%
13.24B
10.01%
average payables
426.63M
-
370.44M
13.17%
398.36M
7.54%
611.43M
53.48%
887.78M
45.20%
1.04B
17.35%
1.28B
22.61%
1.71B
34.18%
2.22B
29.24%
3.00B
35.36%
2.64B
11.79%
average receivables
2.25B
-
-3.31B
247.09%
-5.56B
67.98%
1.68B
130.29%
book value per share
44.33
-
46.89
5.79%
50.39
7.45%
56.20
11.54%
60.71
8.01%
66.32
9.25%
72.87
9.87%
83.01
13.91%
91.01
9.64%
97.89
7.56%
116.34
18.86%
capex per share
-6.20
-
-6.36
2.56%
-5.76
9.37%
-7.01
21.64%
-11.34
61.84%
-10.19
10.15%
-5.10
49.92%
-5.73
12.40%
-6.59
14.90%
-6.07
7.83%
5.01
182.48%
capex to depreciation
-40.12
-
-31.44
21.63%
-30.24
3.79%
-31.86
5.33%
-5.98
81.23%
-7.94
-
capex to operating cash flow
-2.78
-
-1.54
44.78%
-0.41
73.27%
-0.54
-
-0.45
16.77%
capex to revenue
-0.26
-
-0.25
4.00%
-0.20
21.67%
-0.20
1.69%
-0.29
41.67%
-0.20
30.23%
-0.09
55.40%
-0.09
2.36%
-0.08
2.26%
-0.07
18.60%
0.05
172.94%
cash per share
8.12
-
6.05
25.53%
3.78
37.46%
2.60
31.14%
1.64
36.89%
2.09
27.38%
1.42
31.97%
1.51
6.32%
2.62
73.02%
2.55
2.85%
2.36
7.16%
days of inventory on hand
183.75
-
182.29
0.79%
176.82
3.00%
179.97
1.78%
221.49
23.07%
199.02
10.14%
178.88
10.12%
182.96
2.28%
215.34
17.70%
215.36
0.01%
191.88
10.90%
days payables outstanding
24.75
-
21.39
13.54%
23.01
7.53%
34.37
49.40%
38.38
11.67%
32.67
14.87%
38.94
19.16%
46.07
18.31%
47.72
3.59%
58.72
23.05%
54.13
7.82%
days sales outstanding
55.71
-
-117.12
310.21%
debt to assets
0.17
-
0.16
4.54%
0.16
4.23%
0.13
13.55%
0.26
89.87%
0.27
7.13%
0.21
23.51%
0.15
30.31%
0.19
28.04%
0.15
17.95%
0.04
71.84%
debt to equity
0.24
-
0.23
4.74%
0.21
5.23%
0.18
14.33%
0.41
125.57%
0.46
10.33%
0.32
29.07%
0.21
36.25%
0.30
47.85%
0.24
20.27%
0.06
74.28%
dividend yield
0.00
-
0.04
554,913.75%
0.03
26.78%
0.01
75.80%
0.02
192.43%
0.03
38.93%
0.04
29.93%
0.01
67.56%
0.05
255.46%
0.07
57.38%
0.06
16.51%
earnings yield
0.23
-
0.19
18.11%
0.17
10.71%
0.09
47.49%
0.11
27.98%
0.19
65.29%
0.24
26.38%
0.12
50.74%
0.15
26.55%
0.22
46.72%
0.23
4.28%
enterprise value
10.19B
-
12.61B
23.70%
16.27B
29.07%
29.52B
81.40%
33.22B
12.56%
29.10B
12.40%
24.75B
14.97%
51.02B
106.15%
45.99B
9.85%
30.83B
32.96%
28.01B
9.14%
enterprise value over ebitda
3.73
-
4.45
19.17%
5.34
20.08%
8.56
60.23%
8.52
0.51%
5.85
31.31%
4.37
25.34%
7.05
61.45%
5.98
15.16%
4.19
29.92%
3.23
23.06%
ev to operating cash flow
18.26
-
9.83
46.16%
4.46
54.59%
8.37
-
5.07
39.48%
ev to sales
0.97
-
1.12
15.79%
1.25
11.57%
1.90
51.65%
1.88
1.47%
1.28
31.98%
0.97
24.25%
1.73
79.02%
1.33
23.31%
0.79
40.81%
0.63
19.63%
free cash flow per share
-6.20
-
-6.36
2.56%
-5.76
9.37%
-7.01
21.64%
-7.26
3.64%
-3.55
51.06%
7.33
306.20%
-5.73
178.27%
5.72
199.82%
7.56
32.11%
13.74
81.69%
free cash flow yield
-0.45
-
-0.35
22.81%
-0.22
36.72%
-0.12
43.94%
-0.14
16.44%
-0.10
32.36%
0.22
324.82%
-0.06
126.44%
0.07
226.43%
0.16
115.28%
0.24
49.93%
graham net net
-5.94
-
-8.65
45.60%
-11.17
29.12%
-13.00
16.36%
-28.68
120.64%
-33.83
17.97%
-29.88
11.66%
-15.53
48.04%
-51.84
233.83%
-31.21
39.80%
-22.15
29.03%
graham number
56.04
-
60.12
7.28%
70.47
17.22%
79.45
12.73%
88.13
10.93%
100.73
14.30%
113.68
12.85%
146.52
28.89%
153.35
4.66%
150.91
1.59%
177.77
17.80%
income quality
0.72
-
1.07
-
intangibles to total assets
0.01
-
0.01
12.40%
0.01
7.91%
0.01
55.20%
0.04
207.58%
0.04
8.49%
0.04
4.90%
0.04
1.46%
0.08
114.63%
0.08
1.46%
0.08
0.28%
interest coverage
3.65
-
3.34
8.56%
4.02
20.46%
6.19
53.93%
7.45
20.37%
4.92
33.98%
5.53
12.47%
7.75
39.98%
6.89
11.06%
5.61
18.52%
7.48
33.27%
interest debt per share
11.92
-
12.20
2.33%
12.36
1.31%
11.54
6.63%
26.29
127.79%
32.54
23.76%
25.83
20.61%
19.03
26.32%
29.98
57.51%
26.66
11.05%
9.32
65.06%
inventory turnover
1.99
-
2.00
0.80%
2.06
3.09%
2.03
1.75%
1.65
18.75%
1.83
11.29%
2.04
11.26%
1.99
2.23%
1.69
15.04%
1.69
0.01%
1.90
12.24%
invested capital
0.24
-
0.23
4.74%
0.21
5.23%
0.18
14.33%
0.41
125.57%
0.46
10.33%
0.32
29.07%
0.21
36.25%
0.30
47.85%
0.24
20.27%
59.70B
24,573,788,532,027.01%
market cap
6.10B
-
8.11B
32.86%
11.61B
43.21%
25.20B
116.98%
22.43B
10.99%
16.23B
27.65%
14.88B
8.32%
44.06B
196.15%
34.79B
21.05%
21.35B
38.62%
25.87B
21.15%
net current asset value
1.21B
-
285.94M
76.33%
35.17M
87.70%
119.11M
238.67%
-5.04B
4,333.80%
-6.09B
20.68%
-4.27B
29.80%
-1.11B
74.01%
-3.09B
178.53%
-661.26M
78.62%
3.38B
610.61%
net debt to ebitda
1.50
-
1.59
6.00%
1.53
3.63%
1.25
18.14%
2.77
121.01%
2.59
6.47%
1.74
32.69%
0.96
44.80%
1.46
51.57%
1.29
11.56%
0.25
80.85%
net income per share
3.15
-
3.43
8.79%
4.38
27.87%
4.99
13.94%
5.69
13.92%
6.80
19.59%
7.88
15.92%
11.49
45.83%
11.48
0.09%
10.34
9.96%
13.07
26.38%
operating cash flow per share
4.08
-
6.63
62.71%
12.43
87.33%
12.31
-
13.64
10.74%
payables turnover
14.75
-
17.06
15.66%
15.87
7.00%
10.62
33.07%
9.51
10.45%
11.17
17.47%
9.37
16.08%
7.92
15.48%
7.65
3.47%
6.22
18.73%
6.74
8.48%
receivables turnover
6.55
-
-3.12
147.57%
research and ddevelopement to revenue
0.00
-
0.00
4.27%
0.00
0.78%
0.00
0.15%
0.00
0.62%
0.00
21.75%
0.01
225.90%
0.01
12.63%
0.01
1.94%
return on tangible assets
0.05
-
0.05
3.15%
0.06
20.34%
0.07
3.58%
0.06
8.62%
0.06
5.89%
0.07
13.55%
0.10
40.03%
0.08
17.46%
0.07
13.96%
0.09
25.97%
revenue per share
23.52
-
25.12
6.83%
29.06
15.69%
34.76
19.62%
39.71
14.24%
51.15
28.79%
57.44
12.30%
66.11
15.11%
77.71
17.55%
88.00
13.23%
99.51
13.08%
roe
0.07
-
0.07
2.84%
0.09
19.01%
0.09
2.15%
0.09
5.46%
0.10
9.46%
0.11
5.50%
0.14
28.02%
0.13
8.87%
0.11
16.29%
0.12
15.09%
roic
0.06
-
0.07
6.52%
0.09
29.99%
0.09
1.24%
0.08
11.52%
0.09
14.66%
0.10
9.89%
0.12
21.34%
0.10
19.57%
0.10
2.93%
0.13
33.95%
sales general and administrative to revenue
0.04
-
0.04
0.61%
0.03
2.81%
0.03
2.59%
0.03
3.67%
0.03
5.50%
0.03
6.18%
0.03
1.80%
0.03
10.38%
0.03
10.44%
0.03
1.83%
shareholders equity per share
44.33
-
46.89
5.79%
50.39
7.45%
56.20
11.54%
60.71
8.01%
66.32
9.25%
72.87
9.87%
83.01
13.91%
91.01
9.64%
97.89
7.56%
107.48
9.80%
stock based compensation to revenue
tangible asset value
19.58B
-
20.68B
5.66%
22.21B
7.37%
24.61B
10.81%
25.52B
3.72%
27.98B
9.63%
30.98B
10.69%
35.44B
14.41%
39.40B
11.18%
42.22B
7.17%
46.51B
10.14%
tangible book value per share
43.88
-
46.37
5.66%
49.78
7.37%
55.16
10.81%
57.22
3.72%
62.73
9.63%
69.46
10.74%
79.44
14.36%
88.32
11.18%
94.62
7.14%
104.25
10.18%
working capital
4.52B
-
3.66B
19.07%
3.53B
3.51%
5.72B
62.17%
2.33B
59.37%
518.33M
77.72%
1.69B
226.26%
4.42B
161.44%
5.68B
28.55%
7.61B
33.92%
11.26B
47.89%

All numbers in GBP (except ratios and percentages)